Pure H2O Bio Technologies (CE) (USOTC:PRHB)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Pure H2O Bio Technologies (CE) Charts. Click Here for more Pure H2O Bio Technologies (CE) Charts.](/p.php?pid=staticchart&s=NO%5EPRHB&p=8&t=15)
Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) announced today the
results from three successful studies focused on potable water
disinfection treatment for two major microbial threats to human health.
The microorganisms, Escherichia coli (bacterium) and Cryptosporidium
parvum (protozoan parasite of humans), were responsible for
9,877 and 7,212 human cases, respectively, during 2005 according to a
March 2006 American Waterworks Association review article by P. Rochelle
and J. Clancy. Testing conducted for Pure H2O Bio-Technologies, Inc., by
Clancy Environmental Consultants, Inc. showed that activated tetrasilver
tetraoxide (TTO) was effective as a disinfectant for both organisms. TTO
is a unique divalent silver compound, which is produced in a crystalline
form, with disinfectant properties superior to the common forms of
silver.
Joseph P. Doxey, president of Pure H2O Bio-Technologies, Inc. said: "The
results show that the company can use this disinfectant as an
alternative to those which are in current municipal and commercial use
for drinking water treatment. Moreover, these studies on tetrasilver
tetraoxide (patent pending) reported on July 1, 2005, Sept. 8, 2006 and
October 25, 2006, respectively, are significant because Cryptosporidium
oocysts are resistant to halogens such as chlorine and this pathogen has
been known to escape state-of-the-art municipal water treatment systems
and result in many human health outbreaks. E. coli although more easily
disinfected, also has special significance as a waterborne and foodborne
pathogen involved in recent outbreaks."
Reports from the Pure H2O Bio-Technologies studies of July 1, 2005 and
October 25, 2006 showed that low concentrations of TTO, activated by two
different oxidizing agents caused significant reductions in high
concentrations of Cryptosporidium oocysts (highly resistant form of this
waterborne parasite). The Sept. 8, 2006 study showed that
activated/oxidized TTO caused more than a five-log10 reduction of E.
coli (killed more than 100,000 bacteria) in 2 and 5 min. Thus, TTO can
be incorporated into the contained drinking water disinfection system
developed by Pure H20 Bio-Technologies and which will be submitted to
the EPA verification conducted through NSF.
The Company
PHBT is a publicly held company specializing in the manufacturing,
design and sale of its unique residential, commercial and hospital
point-of-use potable water disinfection systems. These systems are
specifically designed to work effectively against water-borne pathogens
and remove heavy metals and objectionable biomass.
Note: The foregoing press release contains forward-looking statements
that can be identified by such terminology as "expects," "potential,"
"suggests," "may," "intends," or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties, and other factors that may cause the actual results to be
materially different from any future results, performance or
achievements expressed or implied by such statements. In particular,
management's expectations regarding future research, development, and/or
commercial results could be affected by, among other things,
uncertainties relating to the availability of future financing;
unexpected regulatory delays or government regulation generally; the
company's ability to obtain or maintain patent and other proprietary
intellectual property protection; and completion in general.
Forward-looking statements speak only as to the date they were made. The
company does not undertake to update forward-looking statements to
reflect circumstances or events that occur after the date the
forward-looking statements are made.
Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) announced today
the results from three successful studies focused on potable water
disinfection treatment for two major microbial threats to human
health. The microorganisms, Escherichia coli (bacterium) and
Cryptosporidium parvum (protozoan parasite of humans), were
responsible for 9,877 and 7,212 human cases, respectively, during 2005
according to a March 2006 American Waterworks Association review
article by P. Rochelle and J. Clancy. Testing conducted for Pure H2O
Bio-Technologies, Inc., by Clancy Environmental Consultants, Inc.
showed that activated tetrasilver tetraoxide (TTO) was effective as a
disinfectant for both organisms. TTO is a unique divalent silver
compound, which is produced in a crystalline form, with disinfectant
properties superior to the common forms of silver.
Joseph P. Doxey, president of Pure H2O Bio-Technologies, Inc.
said: "The results show that the company can use this disinfectant as
an alternative to those which are in current municipal and commercial
use for drinking water treatment. Moreover, these studies on
tetrasilver tetraoxide (patent pending) reported on July 1, 2005,
Sept. 8, 2006 and October 25, 2006, respectively, are significant
because Cryptosporidium oocysts are resistant to halogens such as
chlorine and this pathogen has been known to escape state-of-the-art
municipal water treatment systems and result in many human health
outbreaks. E. coli although more easily disinfected, also has special
significance as a waterborne and foodborne pathogen involved in recent
outbreaks."
Reports from the Pure H2O Bio-Technologies studies of July 1, 2005
and October 25, 2006 showed that low concentrations of TTO, activated
by two different oxidizing agents caused significant reductions in
high concentrations of Cryptosporidium oocysts (highly resistant form
of this waterborne parasite). The Sept. 8, 2006 study showed that
activated/oxidized TTO caused more than a five-log10 reduction of E.
coli (killed more than 100,000 bacteria) in 2 and 5 min. Thus, TTO can
be incorporated into the contained drinking water disinfection system
developed by Pure H20 Bio-Technologies and which will be submitted to
the EPA verification conducted through NSF.
The Company
PHBT is a publicly held company specializing in the manufacturing,
design and sale of its unique residential, commercial and hospital
point-of-use potable water disinfection systems. These systems are
specifically designed to work effectively against water-borne
pathogens and remove heavy metals and objectionable biomass.
Note: The foregoing press release contains forward-looking
statements that can be identified by such terminology as "expects,"
"potential," "suggests," "may," "intends," or similar expressions.
Such forward-looking statements involve known and unknown risks,
uncertainties, and other factors that may cause the actual results to
be materially different from any future results, performance or
achievements expressed or implied by such statements. In particular,
management's expectations regarding future research, development,
and/or commercial results could be affected by, among other things,
uncertainties relating to the availability of future financing;
unexpected regulatory delays or government regulation generally; the
company's ability to obtain or maintain patent and other proprietary
intellectual property protection; and completion in general.
Forward-looking statements speak only as to the date they were made.
The company does not undertake to update forward-looking statements to
reflect circumstances or events that occur after the date the
forward-looking statements are made.